Dextran sulfate facilitates anti-CD4 mAb-induced long-term rat cardiac allograft survival after prolonged cold ischemia

American Journal of Transplantation

Volumn 8, Issue 6, 2008, Pages 1151-1162

  Gajanayake, T ^a   Sawitzki, B ^b   Matozan, K ^a   Korchagina, E Y ^c   Lehmann, M ^d   Volk, H D ^b   Rieben, R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Anti CD4 mAB; Cold ischemia; Complement; Dextran sulfate; Long term graft survival; Rat heart transplantation

Indexed keywords

CD4 ANTIBODY; COMPLEMENT INHIBITOR; DEXTRAN SULFATE; MW 5000;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; COLD ISCHEMIA; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TRANSPLANTATION TOLERANCE; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; COLD ISCHEMIA; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNITY, NATURAL; IMMUNOLOGIC FACTORS; MALE; RATS; RATS, INBRED STRAINS; REPERFUSION INJURY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 44449087475     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02239.x     Document Type: Article

References (45)

1. Coulson MT, Jablonski P, Howden BO, Thomson NM, Stein AN. Beyond operational tolerance: Effect of ischemic injury on development of chronic damage in renal grafts. Transplantation 2005 80 : 353 361.
2. Kang SM, Tang Q, Bluestone JA. CD4+CD25+ regulatory T cells in transplantation: Progress, challenges and prospects. Am J Transplant 2007 7 : 1457 1463.
3. Tanaka M, Mokhtari GK, Terry RD et al. Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. J Heart Lung Transplant 2005 24 : 1906 1914.
4. Knight RJ, Dikman S, Liu H, Martinelli GP. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 1997 64 : 1102 1107.
5. Azuma H, Nadeau K, Takada M, Mackenzie HS, Tilney NL. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997 64 : 190 197.
6. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997 99 : 2682 2690.
7. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997 100 : 1199 1203.
8. Buerke M, Schwertz H, Seitz W, Meyer J, Darius H. Novel small molecule inhibitor of C1 s exerts cardioprotective effects in ischemia-reperfusion injury in rabbits. J Immunol 2001 167 : 5375 5380.
9. Stahl GL, Xu Y, Hao L et al. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 2003 162 : 449 455.
10. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 2003 170 : 1517 1523.
11. de Vries B, Walter SJ, Peutz-Kootstra CJ, Wolfs TG, van Heurn LW, Buurman WA. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. Am J Pathol 2004 165 : 1677 1688.
12. Zhang M, Takahashi K, Alicot EM et al. Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 2006 177 : 4727 4734.
13. Kim BS, Lim SW, Li C et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 2005 79 : 1370 1377.
14. Mulivor AW, Lipowsky HH. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol Heart Circ Physiol 2004 286 : H1672 H1680.
15. Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol 2000 165 : 1599 1604.
16. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002 168 : 5233 5239.
17. Laumonier T, Mohacsi PJ, Matozan KM et al. Endothelial cell protection by dextran sulfate: A novel strategy to prevent acute vascular rejection in xenotransplantation. Am J Transplant 2004 4 : 181 187.
18. Fiorante P, Banz Y, Mohacsi PJ et al. Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models. Xenotransplantation 2001 8 : 24 35.
19. Banz Y, Hess OM, Robson SC et al. Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury. Eur Heart J 2005 26 : 2334 2343.
20. Hutchings A, Wu J, Asiedu C et al. The immune decision toward allograft tolerance in non-human primates requires early inhibition of innate immunity and induction of immune regulation. Transpl Immunol 2003 11 : 335 344.
21. Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR. Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 2006 177 : 5307 5316.
22. Lehmann M, Sternkopf F, Metz F et al. Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 1992 54 : 959 962.
23. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969 57 : 225 229.
24. Sawitzki B, Amersi F, Ritter T et al. Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther 2002 13 : 1495 1504.
25. Sawitzki B, Bushell A, Steger U et al. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 2007 7 : 1091 1102.
26. Laumonier T, Walpen AJ, Maurus CF et al. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells. Transplantation 2003 76 : 838 843.
27. Weiss S, Kotsch K, Francuski M et al. Brain death activates donor organs and is associated with a worse i/r injury after liver transplantation. Am J Transplant 2007 7 : 1584 1593.
28. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: Differences in inflammatory markers after transplantation. Transplantation 2003 76 : 1599 1603.
29. Koning OH, Ploeg RJ, van Bockel JH et al. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997 63 : 1620 1628.
30. Matsui Y, Saiura A, Sugawara Y et al. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade. Physiological Genomics 2003 15 : 199 208.
31. Heslan JM, Renaudin K, Thebault P, Josien R, Cuturi MC, Chiffoleau E. New evidence for a role of allograft accommodation in long-term tolerance. Transplantation 2006 82 : 1185 1193.
32. Hoffmann SC, Hale DA, Kleiner DE et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005 5 : 573 581.
33. Matzinger P. The danger model: A renewed sense of self. Science 2002 296 301 305.
34. Laumonier T, Walpen AJ, Matozan KM et al. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models. Xenotransplantation 2004 11 (3 262 268.
35. Eto N, Kojima I, Uesugi N et al. Protection of endothelial cells by dextran sulfate in rats with thrombotic microangiopathy. J Am Soc Nephrol 2005 16 : 2997 3005.
36. Sacks SH, Zhou W. Allograft rejection: Effect of local synthesis of complement. Springer Semin Immunopathol 2005 27 : 332 344.
37. Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003 75 : 2001 2007.
38. Morita K, Miura M, Paolone DR et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001 167 : 2979 2984.
39. Matsumiya A, Yamaguchi M, Nakano H, Takeda M, Kumada K. Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells. Life Sci 1999 64 : PL9 PL17.
40. Lian RH, Kotwal GJ, Wellhausen SR, Hunt LA, Justus DE. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate. J Immunol 1996 157 : 864 873.
41. Fernandez-Botran R, Yan J, Justus DE. Binding of interferon gamma by glycosaminoglycans: A strategy for localization and/or inhibition of its activity. Cytokine 1999 11 : 313 325.
42. Zeerleder S, Mauron T, Lammle B, Wuillemin WA. Effect of low-molecular weight dextran sulfate on coagulation and platelet function tests. Thrombosis Research 2002 105 : 441 446.
43. Johansson H, Goto M, Dufrane D et al. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006 6 : 305 312.
44. Fujishima M, Omae T, Tanaka K, Iino K, Matsuo O, Mihara H. Controlled trial of combined urokinase and dextran sulfate therapy in patients with acute cerebral infarction. Angiology 1986 37 : 487 498.
45. Schroeder G, Risch K, Kotsch K et al. FTY720 prevents anti-CD4 mAb-induced tolerance but cannot reverse established tolerance in a rat kidney transplantation model. Am J Transplant 2004 4 : 863 871.